DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $100.26 and last traded at $100.26, with a volume of 50 shares changing hands. The stock had previously closed at $102.64.
Wall Street Analyst Weigh In
Separately, UBS Group lowered DiaSorin from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 26th.
Check Out Our Latest Report on DiaSorin
DiaSorin Trading Down 2.3 %
About DiaSorin
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
Read More
- Five stocks we like better than DiaSorin
- Are Penny Stocks a Good Fit for Your Portfolio?
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- What Are Treasury Bonds?
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- 3 REITs to Buy and Hold for the Long Term
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.
